115 related articles for article (PubMed ID: 26965851)
21. Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability.
Montecucco F; Vuilleumier N; Pagano S; Lenglet S; Bertolotto M; Braunersreuther V; Pelli G; Kovari E; Pane B; Spinella G; Pende A; Palombo D; Dallegri F; Mach F; Roux-Lombard P
Eur Heart J; 2011 Feb; 32(4):412-21. PubMed ID: 21224292
[TBL] [Abstract][Full Text] [Related]
22. The intravenous injection of oxidized LDL- or Apolipoprotein B100--Coupled splenocytes promotes Th1 polarization in wildtype and Apolipoprotein E--Deficient mice.
Steinmetz M; Ponnuswamy P; Laurans L; Esposito B; Tedgui A; Mallat Z
Biochem Biophys Res Commun; 2015 Aug; 464(1):306-11. PubMed ID: 26116775
[TBL] [Abstract][Full Text] [Related]
23. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
24. Circulating cytokines reflect the expression of pro-inflammatory cytokines in atherosclerotic plaques.
Edsfeldt A; Grufman H; Asciutto G; Nitulescu M; Persson A; Nilsson M; Nilsson J; Gonçalves I
Atherosclerosis; 2015 Aug; 241(2):443-9. PubMed ID: 26074318
[TBL] [Abstract][Full Text] [Related]
25. Evidence for altered inflammatory and repair responses in symptomatic carotid plaques from elderly patients.
Grufman H; Schiopu A; Edsfeldt A; Björkbacka H; Nitulescu M; Nilsson M; Persson A; Nilsson J; Gonçalves I
Atherosclerosis; 2014 Nov; 237(1):177-82. PubMed ID: 25240113
[TBL] [Abstract][Full Text] [Related]
26. Antibodies against apoB100 peptide 210 inhibit atherosclerosis in apoE
Dunér P; Mattisson IY; Fogelstrand P; Glise L; Ruiz S; Farina C; Borén J; Nilsson J; Bengtsson E
Sci Rep; 2021 Apr; 11(1):9022. PubMed ID: 33907226
[TBL] [Abstract][Full Text] [Related]
27. Associations between circulating IgG antibodies to Apolipoprotein B
Hu W; Zhang X; Han Y; Wang Y; Lei M; Megson IL; Wei J; Jin Y
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30242056
[No Abstract] [Full Text] [Related]
28. High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction.
Sjögren P; Fredrikson GN; Samnegard A; Ericsson CG; Ohrvik J; Fisher RM; Nilsson J; Hamsten A
Eur Heart J; 2008 Sep; 29(18):2218-26. PubMed ID: 18664466
[TBL] [Abstract][Full Text] [Related]
29. Plaque-infiltrating T lymphocytes in patients with carotid atherosclerosis: an insight into the cellular mechanisms associated to plaque destabilization.
Profumo E; Buttari B; Tosti ME; Tagliani A; Capoano R; D'Amati G; Businaro R; Salvati B; Riganò R
J Cardiovasc Surg (Torino); 2013 Jun; 54(3):349-57. PubMed ID: 22669090
[TBL] [Abstract][Full Text] [Related]
30. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization.
Stoll G; Bendszus M
Stroke; 2006 Jul; 37(7):1923-32. PubMed ID: 16741184
[TBL] [Abstract][Full Text] [Related]
31. Humoral immune response against defined oxidized low-density lipoprotein antigens reflects structure and disease activity of carotid plaques.
Gonçalves I; Gronholdt ML; Söderberg I; Ares MP; Nordestgaard BG; Bentzon JF; Fredrikson GN; Nilsson J
Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1250-5. PubMed ID: 15831809
[TBL] [Abstract][Full Text] [Related]
32. Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis.
Vuilleumier N; Bas S; Pagano S; Montecucco F; Guerne PA; Finckh A; Lovis C; Mach F; Hochstrasser D; Roux-Lombard P; Gabay C
Arthritis Rheum; 2010 Sep; 62(9):2640-50. PubMed ID: 20506304
[TBL] [Abstract][Full Text] [Related]
33. High plasma levels of heparin-binding epidermal growth factor are associated with a more stable plaque phenotype and reduced incidence of coronary events.
Rattik S; Wigren M; Björkbacka H; Fredrikson GN; Hedblad B; Siegbahn A; Bengtsson E; Schiopu A; Edsfeldt A; Dunér P; Grufman H; Gonçalves I; Nilsson J
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):222-8. PubMed ID: 25359857
[TBL] [Abstract][Full Text] [Related]
34. Impaired fibrous repair: a possible contributor to atherosclerotic plaque vulnerability in patients with type II diabetes.
Edsfeldt A; Gonçalves I; Grufman H; Nitulescu M; Dunér P; Bengtsson E; Mollet IG; Persson A; Nilsson M; Orho-Melander M; Melander O; Björkbacka H; Nilsson J
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2143-50. PubMed ID: 25035341
[TBL] [Abstract][Full Text] [Related]
35. Vaccination against T-cell epitopes of native ApoB100 reduces vascular inflammation and disease in a humanized mouse model of atherosclerosis.
Gisterå A; Hermansson A; Strodthoff D; Klement ML; Hedin U; Fredrikson GN; Nilsson J; Hansson GK; Ketelhuth DF
J Intern Med; 2017 Apr; 281(4):383-397. PubMed ID: 28194913
[TBL] [Abstract][Full Text] [Related]
36. Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2/CD14 complex.
Pagano S; Satta N; Werling D; Offord V; de Moerloose P; Charbonney E; Hochstrasser D; Roux-Lombard P; Vuilleumier N
J Intern Med; 2012 Oct; 272(4):344-57. PubMed ID: 22329401
[TBL] [Abstract][Full Text] [Related]
37. Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study.
Mayr M; Kiechl S; Tsimikas S; Miller E; Sheldon J; Willeit J; Witztum JL; Xu Q
J Am Coll Cardiol; 2006 Jun; 47(12):2436-43. PubMed ID: 16781371
[TBL] [Abstract][Full Text] [Related]
38. Autoantibodies against aldehyde-modified collagen type IV are associated with risk of development of myocardial infarction.
Vallejo J; Dunér P; Fredrikson GN; Nilsson J; Bengtsson E
J Intern Med; 2017 Dec; 282(6):496-507. PubMed ID: 28944562
[TBL] [Abstract][Full Text] [Related]
39. Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodies.
Fredrikson GN; Björkbacka H; Söderberg I; Ljungcrantz I; Nilsson J
J Intern Med; 2008 Dec; 264(6):563-70. PubMed ID: 18783480
[TBL] [Abstract][Full Text] [Related]
40. The role of oxidized phospholipids, lipoprotein (a) and biomarkers of oxidized lipoproteins in chronically occluded coronary arteries in sudden cardiac death and following successful percutaneous revascularization.
Fefer P; Tsimikas S; Segev A; Sparkes J; Otsuka F; Kolodgie F; Virmani R; Juliano J; Charron T; Strauss BH
Cardiovasc Revasc Med; 2012; 13(1):11-9. PubMed ID: 22079685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
